一个新的前沿领域：CD19嵌合抗原受体T细胞疗法。 - Suppr

Suppr

超能文献

A New Frontier: CD19 Chimeric Antigen Receptor T-Cell Therapy.

作者信息

Alcocer Alkureishi Lolita, Hageman Joseph R

出版信息

Pediatr Ann. 2024 May;53(5):e157-e158. doi: 10.3928/19382359-20240409-01. Epub 2024 May 1.

DOI:10.3928/19382359-20240409-01

PMID:38700917

Abstract

摘要

相似文献

A New Frontier: CD19 Chimeric Antigen Receptor T-Cell Therapy.

Pediatr Ann. 2024 May;53(5):e157-e158. doi: 10.3928/19382359-20240409-01. Epub 2024 May 1.

T-cell malignancies with anti-CD19 chimeric antigen receptor T-cell therapy.

Blood Adv. 2024 Aug 13;8(15):4144-4148. doi: 10.1182/bloodadvances.2024013248.

CD19 CAR T cells for multiple sclerosis: Forging further into the new frontier.

Med. 2024 Jun 14;5(6):482-484. doi: 10.1016/j.medj.2024.04.005.

Chimeric Antigen Receptor T Cell Therapy for Pediatric B-ALL: Narrowing the Gap Between Early and Long-Term Outcomes.

Front Immunol. 2020 Aug 11;11:1985. doi: 10.3389/fimmu.2020.01985. eCollection 2020.

The underlying mechanism of chimeric antigen receptor (CAR)-T cell therapy triggering secondary T-cell cancers: Mystery of the Sphinx?

Cancer Lett. 2024 Aug 10;597:217083. doi: 10.1016/j.canlet.2024.217083. Epub 2024 Jun 24.

CD19 directed CARs in acute lymphoblastic leukemia: state of the art and beyond.

Leuk Lymphoma. 2019 May;60(5):1346-1348. doi: 10.1080/10428194.2018.1533132. Epub 2019 Jan 16.

Steering Chimeric Antigen Receptor T Cells Into the Hodgkin Lymphoma Niche.

J Clin Oncol. 2020 Nov 10;38(32):3816-3818. doi: 10.1200/JCO.20.02351. Epub 2020 Sep 18.

CAR T-Cells and Safety Signals: ITT Episode 29.

N Engl J Med. 2024 Apr 25;390(16):e39. doi: 10.1056/NEJMp2400701.

Chimeric Antigen Receptor-Engineered T Cell Therapy in Lymphoma.

Curr Oncol Rep. 2019 Mar 27;21(5):38. doi: 10.1007/s11912-019-0789-z.

Evidence of long-lasting anti-CD19 activity of engrafted CD19 chimeric antigen receptor-modified T cells in a phase I study targeting pediatrics with acute lymphoblastic leukemia.

Hematol Oncol. 2019 Dec;37(5):601-608. doi: 10.1002/hon.2672. Epub 2019 Sep 15.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

A New Frontier: CD19 Chimeric Antigen Receptor T-Cell Therapy.

作者信息

Alcocer Alkureishi Lolita, Hageman Joseph R

出版信息

Pediatr Ann. 2024 May;53(5):e157-e158. doi: 10.3928/19382359-20240409-01. Epub 2024 May 1.

DOI:10.3928/19382359-20240409-01

PMID:38700917

Abstract

摘要

相似文献

A New Frontier: CD19 Chimeric Antigen Receptor T-Cell Therapy.

Pediatr Ann. 2024 May;53(5):e157-e158. doi: 10.3928/19382359-20240409-01. Epub 2024 May 1.

T-cell malignancies with anti-CD19 chimeric antigen receptor T-cell therapy.

Blood Adv. 2024 Aug 13;8(15):4144-4148. doi: 10.1182/bloodadvances.2024013248.

CD19 CAR T cells for multiple sclerosis: Forging further into the new frontier.

Med. 2024 Jun 14;5(6):482-484. doi: 10.1016/j.medj.2024.04.005.

Chimeric Antigen Receptor T Cell Therapy for Pediatric B-ALL: Narrowing the Gap Between Early and Long-Term Outcomes.

Front Immunol. 2020 Aug 11;11:1985. doi: 10.3389/fimmu.2020.01985. eCollection 2020.

The underlying mechanism of chimeric antigen receptor (CAR)-T cell therapy triggering secondary T-cell cancers: Mystery of the Sphinx?

Cancer Lett. 2024 Aug 10;597:217083. doi: 10.1016/j.canlet.2024.217083. Epub 2024 Jun 24.

CD19 directed CARs in acute lymphoblastic leukemia: state of the art and beyond.

Leuk Lymphoma. 2019 May;60(5):1346-1348. doi: 10.1080/10428194.2018.1533132. Epub 2019 Jan 16.

Steering Chimeric Antigen Receptor T Cells Into the Hodgkin Lymphoma Niche.

J Clin Oncol. 2020 Nov 10;38(32):3816-3818. doi: 10.1200/JCO.20.02351. Epub 2020 Sep 18.

CAR T-Cells and Safety Signals: ITT Episode 29.

N Engl J Med. 2024 Apr 25;390(16):e39. doi: 10.1056/NEJMp2400701.

Chimeric Antigen Receptor-Engineered T Cell Therapy in Lymphoma.

Curr Oncol Rep. 2019 Mar 27;21(5):38. doi: 10.1007/s11912-019-0789-z.

Evidence of long-lasting anti-CD19 activity of engrafted CD19 chimeric antigen receptor-modified T cells in a phase I study targeting pediatrics with acute lymphoblastic leukemia.

Hematol Oncol. 2019 Dec;37(5):601-608. doi: 10.1002/hon.2672. Epub 2019 Sep 15.